This case report details the successful management of a 99-year old lymphoma patient.
Browsing: Journals > International Journal of Hematologic Oncology
In this review article from the International Journal of Hematologic Oncology read about the clinical benefits of utilizing tyrosine kinase inhibitors in combination with chemotherapy regimes for Philadelphia chromosome-positive acute lymphoblastic leukemia patients.
This review article from the International Journal of Hematologic Oncology offers a detailed overview of the role of B-cell receptor signaling pathways in B-cell malignancies, discussing how a greater understanding of such pathways has led to the discovery of numerous drug targets.
This review presents an update on recent progress in characterizing recurrent genetic abnormalities in AML, focusing on prognostic significance and therapeutic implications.
Learn further about the mechanism of action of currently available and future immunotherapy strategies for multiple myeloma, while also exploring ways in which treatment may be more specifically directed in the future.
Read more on the compelling challenge of treating elderly patients with CLL in this excellent review article from our partner journal, the International Journal of Hematologic Oncology.
This review discusses the role of cytotoxic chemotherapy in the management of NETs with an overview of past and present clinical trials, current treatment guidelines and future directions.
The integration of the MRD-based strategy with improved pediatric-type regimens and novel targeting agents for discrete ALL subsets is increasing the cure rate to above 50%. this article discusses the reasons behind this.
This article discusses the need to move from empiric chemotherapy to targeted therapies for future treatment of large granular lymphocyte leukemia.
Aim: We conducted a retrospective single center study to measure bone healing by conventional x-ray radiographs (CXR) and computer tomography…